Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 12:47:53 GMT 2023
by
admin
on
Sat Dec 16 12:47:53 GMT 2023
|
Protein Type | ENZYME |
Protein Sub Type | MONOAMINE OXIDASE |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
3OV8HVI592
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
P27338
Created by
admin on Sat Dec 16 12:47:55 GMT 2023 , Edited by admin on Sat Dec 16 12:47:55 GMT 2023
|
PRIMARY | |||
|
MONOAMINE OXIDASE B
Created by
admin on Sat Dec 16 12:47:55 GMT 2023 , Edited by admin on Sat Dec 16 12:47:55 GMT 2023
|
PRIMARY | |||
|
3OV8HVI592
Created by
admin on Sat Dec 16 12:47:55 GMT 2023 , Edited by admin on Sat Dec 16 12:47:55 GMT 2023
|
PRIMARY | |||
|
EC 1.4.3.4
Created by
admin on Sat Dec 16 12:47:55 GMT 2023 , Edited by admin on Sat Dec 16 12:47:55 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
IC50
|
||
|
RADIOLIGAND->TARGET |
|
||
|
INHIBITOR -> METABOLIC ENZYME |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> METABOLIC ENZYME |
|
||
|
INHIBITOR -> METABOLIC ENZYME |
|
||
|
RADIOLIGAND->TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
IRREVERSIBLE INHIBITOR
|
||
|
INHIBITOR -> METABOLIC ENZYME |
|
||
|
INHIBITOR -> METABOLIC ENZYME |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> METABOLIC ENZYME |
|
||
|
SUBSTRATE->ENZYME |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
SUBSTRATE -> METABOLIC ENZYME |
|
||
|
INHIBITOR -> TARGET |
|
||
|
SUBSTRATE -> METABOLIC ENZYME |
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> METABOLIC ENZYME |
|
||
|
INHIBITOR -> METABOLIC ENZYME |
|
||
|
INHIBITOR -> METABOLIC ENZYME |
|
||
|
INHIBITOR -> TARGET |
IRREVERSIBLE INHIBITOR
|
||
|
INHIBITOR -> TARGET |
|
||
|
INHIBITOR -> METABOLIC ENZYME |
MAO inhibition can lead to peripheral or central neurotransmitter accumulation, with potentially serious consequences. MAO inhibitors, when taken in combination with vasoconstrictors, such as pseudoephedrine, or high dietary tyramine can cause sudden blood pressure elevations that may lead to hypertensive crises. Combination with serotonergic agents may lead to rare, but potentially life-threatening, serotonin syndrome
IC50
|
||
|
RADIOLIGAND->TARGET |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER AVERAGE(CALCULATED) | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|